Ashkon Software



BOUT - Innovator Ibd Breakout Opportunities ETF

Innovator Ibd Breakout Opportunities ETF logoInnovator IBD Breakout Opportunities ETF is a US-based exchange-traded fund that seeks to provide exposure to companies that are experiencing a period of positive momentum and potential price appreciation. The ETF tracks the IBD Breakout Stocks Index, which is comprised of companies with a market capitalization of at least $1 billion that are exhibiting strong price momentum as identified by Investor's Business Daily's proprietary system.

The ETF's portfolio is relatively concentrated, with approximately 50 holdings. Its top holdings are in the technology and healthcare sectors, which together make up more than half of the portfolio. The ETF's expense ratio is 0.80%, which is higher than the average expense ratio for ETFs.

Investors interested in BOUT should keep in mind that the fund's concentration in certain sectors may lead to higher volatility and risk. Additionally, since the ETF uses a momentum-based strategy, it may not perform as well during market downturns or periods of lower volatility.

Overall, Innovator IBD Breakout Opportunities ETF may be suitable for investors looking for exposure to companies with strong price momentum and potential for further price appreciation, but they should be aware of the higher expense ratio and concentration risks associated with the fund.




Copyright © 2000-2023, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer